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Sacrococcygeal teratoma is a rare fetal neoplasm with an incidence of 1 in 40,000 births.
Antenatal diagnosis is usually made after 22 weeks of gestation. Fetuses with this
malformation are at risk of significant perinatal morbidity and mortality. Malignant
components, coexisting with life-threatening anomalies, and chromosomal abnormalities are
rare. Postulated causes of perinatal death include hydrops, dystocia, tumor rupture, preterm
labor secondary to polyhydramnios, and anemia due either to hemorrhage or hemolysis
within the tumor. Herein, we present a case of fetal sacrococcygeal teratoma diagnosed as
early as 17 weeks of gestation.
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Sacrococcygeal teratoma is a rare congenital neoplasm
in the fetus, occurring in 1 in 40,000 infants. These
teratomas are derived from pluripotent cells in
Hensen’s node of the primitive streak and contain
components arising from all three layers. Prenatal
diagnosis by ultrasound may reveal a mass of either
cystic, solid, or mixed appearance in the sacral area
protruding through the perineum. Altman et al
classified sacrococcygeal teratomas into four types
according to their location [1]. Type 1 is the most
common and is predominantly external, protruding
from the perineal region with a minimal pre-sacral
component. Type 2 appears externally with a
significant intra-pelvic portion. Type 3 is usually visible
and extends into the abdominal cavity. Type 4 is
completely within the pre-sacral area and has no
external component. This classification depends on
the relationship between extra- and intra-pelvic parts
and is considered descriptive with no prognostic value.
Approximately 75% of affected infants are female.
Most fetal sacrococcygeal teratomas are diagnosed
between 22 and 34 weeks of gestation by prenatal
sonography [2]. We present the case of a male fetus
diagnosed at 17 weeks of gestation.
CASE PRESENTATION
A 28-year-old woman (gravida 4, para 2) was referred
to our hospital at 17 weeks of gestation with the chief
problem of a fetal sacral mass. There was no contributory
factor in her obstetric or other medical history.
Sonographically, the tumor mass was 3.5 x 4.0 cm with a
complex cystic structure (Figure 1). No polyhydramnios,
placentomegaly, abdominal wall edema, or pericardial
effusion was found. After detailed discussion with the
patient and her family, termination of pregnancy was
accomplished through vaginal delivery by induction.
A male infant weighing 250 g was delivered with
Apgar scores of 0 and 0 at 1 and 5 minutes (Figure 2).
© 2003 Elsevier. All rights reserved.
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DISCUSSION
The present case showed a complex cystic tumor in the
sacral region of a male fetus which was diagnosed as
a Type 1 sacrococcygeal teratoma. In general, a
sacrococcygeal teratoma appears on the sonogram as
a large mass attached to the fetal rump, projecting
from the coccyx with polyhydramnios .  The
components may be purely solid, cystic, or a complex
of both. The purely cystic form may be misdiagnosed
as a myelomeningocele. The posterior spinal elements
are preserved in sacrococcygeal teratoma, which
distinguish it from myelomeningocele.
Sacrococcygeal teratomas are usually 7 to 8 cm in
size. However, a sacrococcygeal teratoma of more
than 25 cm has been reported [3]. Clinical features
combined with hydrops and/or placentomegaly have
great predictive value for prognosis. There were no
such findings in the present case. Adjuvant imaging
techniques such as magnetic resonance imaging (MRI)
may be used to assess prognosis. However, although
MRI is helpful for accurately defining the intra-pelvic
extent of the sacrococcygeal teratoma, it cannot provide
details of the extra-pelvic tumor, including the
vascularity and differentiation of the tumor type. Ultra-
fast T2 weighted imaging enables clear visualization
of morphologic details of the fetus without motion
artifacts [4].
Up to 18% of cases in a neonatal series have other
abnormalities, for example, spina bifida or sacral
agenesis [1]. However, karyotype study is usually
normal. The differential diagnosis of a large mass
projecting from the rump of a fetus includes lipoma,
hemangioma, rhabdomyoma, sarcoma, dorsal midline
hamartoma, and, if cystic, meningomyelocele. In a
fetus with sacrococcygeal teratoma, obstetric
complications include polyhydramnios, pre-eclampsia,
hydrops, and preterm delivery. Among these,
polyhydramnios can develop suddenly and contribute
to the possibility of preterm labor. Placentomegaly
can also be present with maternal pre-eclampsia. If
sacrococcygeal teratoma causes venous compression,
high-output cardiac failure and hydrops will result in
a very poor prognosis for the fetus. However, if hydrops
develops remote from term, fetal surgery may be an
option for management. Langer et al reported a case of
fetal surgery for sacrococcygeal teratoma performed
at 21 weeks’ gestation after development of hydrops,
placentomegaly, and preterm labor [5]. Tumor
Figure 1. A protruding tumor in the sacral region.
Figure 2. Male infant with sacrococcygeal teratoma at 17 weeks
of gestation.
The clinical course was smooth. Pathologic study of
the tumor revealed an immature teratoma primarily
composed of  neuroectodermal elements,  i .e .
neuroepithelial rosettes.
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resection caused reversal of the hydrops, but
intractable preterm labor developed. Nakayama
suggested that fetal surgery may be indicated in
patients with hydrops before 28 weeks’ gestation [6].
This probably provides the best balance between the
risks of fetal surgery and fetal death from hydrops.
The predictors of a poor outcome for a fetus with
sacrococcygeal teratoma include diagnosis before 20
weeks’ gestation, delivery before 30 weeks’ gestation,
and hydrops. Low birth weight and/or Apgar score
less than 7 have also been regarded as predictors of
poor prognosis [7]. In our present case, poor outcome
for the fetus was expected. In a study of 29 cases,
Kuhlmann et al reported an inverse correlation
between tumor size and outcome [7].
Close sonographic (two- and three-dimensional)
observation is the first step in the management of fetal
sacrococcygeal teratoma, to monitor fetal growth and
changes in tumor size and to assess the development
of hydrops. In cases of symptomatic polyhydramnios
and to prevent preterm delivery, volume reduction by
amniocentesis and treatment with tocolysis are
probably useful.
Barring the development of hydrops or maternal
complications, delayed termination of pregnancy is
suggested to allow fetal maturation. Gross et al
recommended cesarean delivery in all fetuses with a
sacrococcygeal teratoma of more than 5 cm [8]. An
optimal uterine incision is important to avoid fetal
injury and minimize the risk of tumor rupture. For this
purpose, a vertical uterine incision can be used. In
general, malignant changes in fetal sacrococcygeal
teratomas are rare, including microscopic malignant
foci, which may lead to the recurrence of a tumor that
was initially thought to be benign. Therefore, it is
strongly suggested that infants with sacrococcygeal
teratoma should be followed closely for at least 3
years. We report this case to address not only its rarity,
but also its diagnosis as early as 17 weeks of gestation.
REFERENCES
1. Altman RP, Randolph JG, Lilly JR. Sacrococcygeal teratoma:
American Academy of Pediatrics Surgical Section Survey-
1973. J Pediatr Surg 1974;9:389–98.
2. Flake AW, Harrison MR, Adzick NS, et al. Fetal sacrococcygeal
teratoma. J Pediatr Surg 1986;21:563–6.
3. Valdiserri RO, Yunis EJ. Sacrococcygeal teratomas: a review of
68 cases. Cancer 1981;48:217–21.
4. Okamura M, Kurauchi O, Itakura A, et al. Fetal sacrococcygeal
teratoma visualized by ultra-fast T2 weighted magnetic
resonance imaging. Int J Gynecol Obstet 1999;65:191–3.
5. Langer JC, Harrison MR, Schmidt KG, et al. Fetal hydrops and
death from sacrococcygeal teratoma: rationale for fetal surgery.
Am J Obstet Gynecol 1989;160:1145–50.
6. Nakayama DK. Survival in a fetus with sacrococcygeal
teratoma and hydrops. Am J Obstet Gynecol 1990;163:682.
7. Kuhlmann RS, Warsof SL, Levy DL, et al. Fetal sacrococcygeal
teratoma. Fetal Ther 1987;2:95–100.
8. Gross SJ, Benzie RJ, Sermer M, et al. Sacrococcygeal teratoma:
prenatal diagnosis and management. Am J Obstet Gynecol
1987;156:393–6.
